IFLScience on MSN
New personalized mRNA vaccine keeps pancreatic cancer at bay 6 years after treatment
An experimental personalized therapy that treats aggressive pancreatic cancer using mRNA vaccine technology is still ...
Hosted on MSN
How the mRNA technology behind COVID-19 vaccines could ‘turbo-charge’ cancer treatments
The mRNA technology from COVID-19 vaccines may help amplify cancer treatments that use the body’s own immune system to fight cancer, a new study has found. Cancer patients who received an mRNA-based ...
The U.S. helped pioneer the technology, but new funding cuts may shift breakthroughs — and industry leadership — overseas.
The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer/BioNtech COVID-19 vaccine. "We feel that a cure for cancer or to changing cancer patients' ...
Moderna says the first doses have been administered in a trial of an HIV vaccine that uses mRNA technology, which is also used in its COVID-19 vaccine. "We believe that mRNA offers a unique ...
WASHINGTON — The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday. The ...
A study showed that non-immune cells shape mRNA vaccine responses. Expression of mRNA in muscle cells increased immunity, ...
Local health experts say the U.S. Food and Drug Administration’s refusal to consider Moderna’s application for a new flu vaccine made with mRNA technology is a “shock” and threatens the development of ...
The U.S. Food and Drug Administration (FDA) is reviewing a new flu vaccine for adults age 50 and older. If approved, it would be the first influenza shot to use mRNA technology, and experts say it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results